Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

NCT06928272 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Long COVID

Interventions

DRUG: Pirfenidone
DRUG: Placebo for pirfenidone
DRUG: Upadacitinib
DRUG: Placebo for upadacitinib

Sponsor

Douglas D. Fraser